Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,400 | 149,600 | 145,400 | 74,400 | 91,800 |
| Receivables | 123,800 | 115,300 | 118,000 | 137,000 | 120,400 |
| Inventories | 27,900 | 30,600 | 31,600 | 28,700 | 28,300 |
| TOTAL | $312,800 | $332,600 | $344,800 | $284,300 | $287,200 |
| Non-Current Assets | |||||
| PPE Net | 111,500 | 114,000 | 111,400 | 113,000 | 114,000 |
| Intangibles | 192,800 | 205,000 | 214,700 | 221,700 | 543,800 |
| Other Non-Current Assets | 56,600 | 55,000 | 57,200 | 58,300 | 61,100 |
| TOTAL | $360,900 | $374,000 | $383,300 | $393,000 | $718,900 |
| Total Assets | $673,700 | $706,600 | $728,100 | $677,300 | $1,006,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 59,400 | N/A |
| Accounts payable and accrued liabilities | 32,600 | 30,000 | 31,800 | 30,900 | 28,100 |
| Accrued Expenses | 90,500 | 96,900 | 108,300 | 100,600 | 112,100 |
| TOTAL | $130,200 | $133,800 | $148,000 | $199,900 | $151,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 120,300 | 119,900 | 119,500 | 0 | 59,300 |
| Other Non-Current Liabilities | 85,800 | 84,900 | 87,800 | 89,300 | 90,800 |
| TOTAL | $206,100 | $204,800 | $207,300 | $89,300 | $150,100 |
| Total Liabilities | $336,300 | $338,600 | $355,300 | $289,200 | $301,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,448 | 93,508 | 93,214 | 93,045 | 92,177 |
| Common Shares | 900 | 900 | 900 | 900 | 900 |
| Retained earnings | -1,156,800 | -1,122,700 | -1,114,800 | -1,087,400 | -756,900 |
| Other shareholders' equity | 700 | 800 | -100 | -100 | -600 |
| TOTAL | $337,400 | $368,000 | $372,800 | $388,100 | $704,900 |
| Total Liabilities And Equity | $673,700 | $706,600 | $728,100 | $677,300 | $1,006,100 |